Taken together, these results revealed an overexpression of both UBE2S and UBE2C and a downregulation of Numb in breast cancer, indicating the oncogenic effects of UBE2S and UBE2C and the tumor suppressive role of Numb in breast cancer. The gene discussed is UBE2C; the disease is breast cancer.